 | • レポートコード：QYR9ST03838 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、気管支肺異形成の世界市場について調査・分析し、気管支肺異形成の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（界面活性剤補充療法、酸素療法、支持療法、その他）、用途別（クリニック、病院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の気管支肺異形成市場動向 ・主要企業別マーケットシェア ・気管支肺異形成の種類別市場規模2014-2019 （界面活性剤補充療法、酸素療法、支持療法、その他） ・気管支肺異形成の用途別市場規模2014-2019 （クリニック、病院、その他） ・気管支肺異形成の北米市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成の中国市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成の日本国内市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成の東南アジア市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成のインド市場：主要企業・種類別/用途別市場規模 ・気管支肺異形成の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Chiesi Farmaceutici、Discovery Laboratories、Takeda Pharmaceutical Company、MediPost、Clarassance、Syntrix Biosystems） ・気管支肺異形成の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Bronchopulmonary dysplasia, a type of chronic lung disorder, affects newborns, mostly premature and infants. Lungs and bronchi are damaged at the neonatal phase which causes destruction of tiny air sacs known as alveoli. Babies are not born with the disease. The condition is developed when premature infants need aid to breathe for a longer period, leading to inflammation and lung scarring. Infants with this disease exhibit signs and symptoms such as rapid breathing and faster heart rate. The disease is life threatening however, the severity of the disease varies.The global bronchopulmonary dysplasia treatment market is expected to expand at a steady CAGR during the forecast period. According to the Journal of Clinical Medicine, 10,000 to 15,000 new cases of the disorder are reported each year in the U.S. alone. High prevalence of the diseases is expected to drive the global bronchopulmonary dysplasia treatment market during the forecast period. According to the WHO, 15 million babies are born preterm which is another factor contributing to the growth of the market. Furthermore, government initiatives, favorable reimbursement policies, launch of novel drugs, strong pipeline, rising premature birth cases, and increase in health care expenditure are factors likely to propel the global bronchopulmonary dysplasia treatment market during the forecast period. Long-term side effects of drugs, high cost of treatment, and lack of awareness in developing countries are factors anticipated to restrain the global market during the forecast period.
In 2018, the global Bronchopulmonary Dysplasia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Bronchopulmonary Dysplasia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bronchopulmonary Dysplasia development in United States, Europe and China.
The key players covered in this study
Chiesi Farmaceutici
Discovery Laboratories
Takeda Pharmaceutical Company
MediPost
Clarassance
Syntrix Biosystems
…
Market segment by Type, the product can be split into
Surfactant Replacement Therapy
Oxygen Therapy
Supportive Therapy
Others
Market segment by Application, split into
Clinic
Hospital
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Bronchopulmonary Dysplasia status, future forecast, growth opportunity, key market and key players.
To present the Bronchopulmonary Dysplasia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Bronchopulmonary Dysplasia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type (2014-2025)
1.4.2 Surfactant Replacement Therapy
1.4.3 Oxygen Therapy
1.4.4 Supportive Therapy
1.4.5 Others
1.5 Market by Application
1.5.1 Global Bronchopulmonary Dysplasia Market Share by Application (2014-2025)
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Bronchopulmonary Dysplasia Market Size
2.2 Bronchopulmonary Dysplasia Growth Trends by Regions
2.2.1 Bronchopulmonary Dysplasia Market Size by Regions (2014-2025)
2.2.2 Bronchopulmonary Dysplasia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Bronchopulmonary Dysplasia Market Size by Manufacturers
3.1.1 Global Bronchopulmonary Dysplasia Revenue by Manufacturers (2014-2019)
3.1.2 Global Bronchopulmonary Dysplasia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bronchopulmonary Dysplasia Market Concentration Ratio (CR5 and HHI)
3.2 Bronchopulmonary Dysplasia Key Players Head office and Area Served
3.3 Key Players Bronchopulmonary Dysplasia Product/Solution/Service
3.4 Date of Enter into Bronchopulmonary Dysplasia Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Bronchopulmonary Dysplasia Market Size by Type (2014-2019)
4.2 Global Bronchopulmonary Dysplasia Market Size by Application (2014-2019)
5 United States
5.1 United States Bronchopulmonary Dysplasia Market Size (2014-2019)
5.2 Bronchopulmonary Dysplasia Key Players in United States
5.3 United States Bronchopulmonary Dysplasia Market Size by Type
5.4 United States Bronchopulmonary Dysplasia Market Size by Application
6 Europe
6.1 Europe Bronchopulmonary Dysplasia Market Size (2014-2019)
6.2 Bronchopulmonary Dysplasia Key Players in Europe
6.3 Europe Bronchopulmonary Dysplasia Market Size by Type
6.4 Europe Bronchopulmonary Dysplasia Market Size by Application
7 China
7.1 China Bronchopulmonary Dysplasia Market Size (2014-2019)
7.2 Bronchopulmonary Dysplasia Key Players in China
7.3 China Bronchopulmonary Dysplasia Market Size by Type
7.4 China Bronchopulmonary Dysplasia Market Size by Application
8 Japan
8.1 Japan Bronchopulmonary Dysplasia Market Size (2014-2019)
8.2 Bronchopulmonary Dysplasia Key Players in Japan
8.3 Japan Bronchopulmonary Dysplasia Market Size by Type
8.4 Japan Bronchopulmonary Dysplasia Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Bronchopulmonary Dysplasia Market Size (2014-2019)
9.2 Bronchopulmonary Dysplasia Key Players in Southeast Asia
9.3 Southeast Asia Bronchopulmonary Dysplasia Market Size by Type
9.4 Southeast Asia Bronchopulmonary Dysplasia Market Size by Application
10 India
10.1 India Bronchopulmonary Dysplasia Market Size (2014-2019)
10.2 Bronchopulmonary Dysplasia Key Players in India
10.3 India Bronchopulmonary Dysplasia Market Size by Type
10.4 India Bronchopulmonary Dysplasia Market Size by Application
11 Central & South America
11.1 Central & South America Bronchopulmonary Dysplasia Market Size (2014-2019)
11.2 Bronchopulmonary Dysplasia Key Players in Central & South America
11.3 Central & South America Bronchopulmonary Dysplasia Market Size by Type
11.4 Central & South America Bronchopulmonary Dysplasia Market Size by Application
12 International Players Profiles
12.1 Chiesi Farmaceutici
12.1.1 Chiesi Farmaceutici Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bronchopulmonary Dysplasia Introduction
12.1.4 Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.1.5 Chiesi Farmaceutici Recent Development
12.2 Discovery Laboratories
12.2.1 Discovery Laboratories Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bronchopulmonary Dysplasia Introduction
12.2.4 Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.2.5 Discovery Laboratories Recent Development
12.3 Takeda Pharmaceutical Company
12.3.1 Takeda Pharmaceutical Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bronchopulmonary Dysplasia Introduction
12.3.4 Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.3.5 Takeda Pharmaceutical Company Recent Development
12.4 MediPost
12.4.1 MediPost Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bronchopulmonary Dysplasia Introduction
12.4.4 MediPost Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.4.5 MediPost Recent Development
12.5 Clarassance
12.5.1 Clarassance Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bronchopulmonary Dysplasia Introduction
12.5.4 Clarassance Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.5.5 Clarassance Recent Development
12.6 Syntrix Biosystems
12.6.1 Syntrix Biosystems Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bronchopulmonary Dysplasia Introduction
12.6.4 Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2014-2019)
12.6.5 Syntrix Biosystems Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Bronchopulmonary Dysplasia Key Market Segments
Table Key Players Bronchopulmonary Dysplasia Covered
Table Global Bronchopulmonary Dysplasia Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bronchopulmonary Dysplasia Market Size Market Share by Type 2014-2025
Figure Surfactant Replacement Therapy Figures
Table Key Players of Surfactant Replacement Therapy
Figure Oxygen Therapy Figures
Table Key Players of Oxygen Therapy
Figure Supportive Therapy Figures
Table Key Players of Supportive Therapy
Figure Others Figures
Table Key Players of Others
Table Global Bronchopulmonary Dysplasia Market Size Growth by Application 2014-2025 (Million US$)
Figure Clinic Case Studies
Figure Hospital Case Studies
Figure Others Case Studies
Figure Bronchopulmonary Dysplasia Report Years Considered
Table Global Bronchopulmonary Dysplasia Market Size 2014-2025 (Million US$)
Figure Global Bronchopulmonary Dysplasia Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bronchopulmonary Dysplasia Market Size by Regions 2014-2025 (Million US$)
Table Global Bronchopulmonary Dysplasia Market Size by Regions 2014-2019 (Million US$)
Table Global Bronchopulmonary Dysplasia Market Share by Regions 2014-2019
Figure Global Bronchopulmonary Dysplasia Market Share by Regions 2014-2019
Figure Global Bronchopulmonary Dysplasia Market Share by Regions 2019
Table Market Top Trends
Table Global Bronchopulmonary Dysplasia Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bronchopulmonary Dysplasia Market Share by Manufacturers (2014-2019)
Figure Global Bronchopulmonary Dysplasia Market Share by Manufacturers in 2018
Table Global Bronchopulmonary Dysplasia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bronchopulmonary Dysplasia Product/Solution/Service
Table Date of Enter into Bronchopulmonary Dysplasia Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table Global Bronchopulmonary Dysplasia Market Size Share by Type (2014-2019)
Figure Global Bronchopulmonary Dysplasia Market Size Market Share by Type (2014-2019)
Table Global Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table Global Bronchopulmonary Dysplasia Market Size Share by Application (2014-2019)
Figure Global Bronchopulmonary Dysplasia Market Size Market Share by Application (2014-2019)
Figure Global Bronchopulmonary Dysplasia Revenue Market Share by Application in 2018
Figure United States Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table United States Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table United States Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table United States Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table United States Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table United States Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table United States Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure Europe Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table Europe Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table Europe Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table Europe Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table Europe Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table Europe Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table Europe Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure China Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table China Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table China Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table China Bronchopulmonary Dysplasia Market Size by Type (2014-20189) (Million US$)
Table China Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table China Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table China Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure Japan Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table Japan Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table Japan Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table Japan Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table Japan Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table Japan Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table Japan Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure Southeast Asia Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table Southeast Asia Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table Southeast Asia Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure India Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table India Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table India Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table India Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table India Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table India Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table India Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Figure Central & South America Bronchopulmonary Dysplasia Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bronchopulmonary Dysplasia Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bronchopulmonary Dysplasia Market Share (2018-2019)
Table Central & South America Bronchopulmonary Dysplasia Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bronchopulmonary Dysplasia Market Share by Type (2014-2019)
Table Central & South America Bronchopulmonary Dysplasia Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bronchopulmonary Dysplasia Market Share by Application (2014-2019)
Table Chiesi Farmaceutici Company Details
Table Chiesi Farmaceutici Revenue in Bronchopulmonary Dysplasia Business (2014-2019) (Million US$)
Figure Chiesi Farmaceutici Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table Chiesi Farmaceutici Recent Development
Table Discovery Laboratories Company Details
Table Discovery Laboratories Revenue in Bronchopulmonary Dysplasia Business (2014-2019)(Million US$)
Figure Discovery Laboratories Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table Discovery Laboratories Recent Development
Table Takeda Pharmaceutical Company Company Details
Table Takeda Pharmaceutical Company Revenue in Bronchopulmonary Dysplasia Business (2014-2019)(Million US$)
Figure Takeda Pharmaceutical Company Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table Takeda Pharmaceutical Company Recent Development
Table MediPost Company Details
Table MediPost Revenue in Bronchopulmonary Dysplasia Business (2014-2019)(Million US$)
Figure MediPost Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table MediPost Recent Development
Table Clarassance Company Details
Table Clarassance Revenue in Bronchopulmonary Dysplasia Business (2014-2019)(Million US$)
Figure Clarassance Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table Clarassance Recent Development
Table Syntrix Biosystems Company Details
Table Syntrix Biosystems Revenue in Bronchopulmonary Dysplasia Business (2014-2019)(Million US$)
Figure Syntrix Biosystems Revenue Growth Rate in Bronchopulmonary Dysplasia Business (2014-2019)
Table Syntrix Biosystems Recent Development
Table Global Bronchopulmonary Dysplasia Market Size by Regions (Million US$) 2019-2025
Figure Global Bronchopulmonary Dysplasia Market Size Share by Regions (2019-2025)
Figure Global Bronchopulmonary Dysplasia Market Size Share by Regions in 2025
Figure United States Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure China Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure India Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bronchopulmonary Dysplasia Market Size Forecast (2019-2025)(Million USD)
Table Global Bronchopulmonary Dysplasia Market Size by Product (2019-2025) (Million US$)
Figure Global Bronchopulmonary Dysplasia Market Size by Product (2019-2025)
Figure Global Bronchopulmonary Dysplasia Market Size by Product in 2025
Table Global Bronchopulmonary Dysplasia Market Size by Application (2019-2025) (Million US$)
Figure Global Bronchopulmonary Dysplasia Market Size by Application (2019-2025)
Figure Global Bronchopulmonary Dysplasia Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ホルモン補充療法の世界市場：市場規模・現状・予測 Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Hormonal imbalance disorders, with an increase in the ger…- 子宮頸部形成異常治療の世界市場：市場規模・現状・予測 A precancerous condition where abnormal cell growth occurs at the opening of the cervix is known as cervical dysplasia. Alternatively, it is known as cervical intraepithelial neoplasia. This disease affects the women of all ages but occurs commonly in the age group of 25 to 35 years old. The cervica…
- 子宮頸部形成異常治療の世界市場：市場規模・現状・予測 A precancerous condition where abnormal cell growth occurs at the opening of the cervix is known as cervical dysplasia. Alternatively, it is known as cervical intraepithelial neoplasia. This disease affects the women of all ages but occurs commonly in the age group of 25 to 35 years old. The cervica…
- 血友病A及びB組換え因子補充療法の世界市場：市場規模・現状・予測 Haemophilia is a group of inherited genetic disorders which causes abnormal or exaggerated bleeding. It impairs the normal mechanism of blood clotting after an injury. Internal bleeding inside the joint or inside brain is commonly seen in the patients with severe to moderate haemophilia. Its symptom…
- 子宮頸部形成異常の世界市場：市場規模・現状・予測 Cervical dysplasia is a precancerous condition in which abnormal cell growth occurs on the surface lining of the cervix or endocervical canal, the opening between the uterus and the vagina. It is also called cervical intraepithelial neoplasia (CIN).In 2018, the global Cervical Dysplasia market size …